Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
Vivian E Saper, Michael J. Ombrello, Adriana H. Tremoulet, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 3, pp. 406-415
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Cytokine Storm Syndrome
Randy Q. Cron, Gaurav Goyal, W. Winn Chatham
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 321-337
Open Access | Times Cited: 90
Biological and clinical roles of IL-18 in inflammatory diseases
Emily Landy, Hallie Carol, Aaron M. Ring, et al.
Nature Reviews Rheumatology (2023) Vol. 20, Iss. 1, pp. 33-47
Closed Access | Times Cited: 60
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 27
EULAR/PReS recommendations for the diagnosis and management of Still’s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still’s disease
Bruno Fautrel, Stéphane Mitrovic, Arianna De Matteis, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 12, pp. 1614-1627
Closed Access | Times Cited: 19
Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis
Guangbo Chen, Gail Deutsch, Grant S. Schulert, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 7, pp. 1271-1283
Open Access | Times Cited: 41
Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions
Andrew Gibson, Pooja Deshpande, Chelsea N Campbell, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 2, pp. 289-300.e4
Open Access | Times Cited: 40
Immune dysregulation
Andrew M. Long, Anatole Kleiner, R. John Looney
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 1, pp. 70-80
Open Access | Times Cited: 32
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis
Brian M. Wei, Lindy P. Fox, Benjamin H. Kaffenberger, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 5, pp. 885-908
Closed Access | Times Cited: 31
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses
Giuseppe A. Ramirez, Marco Ripa, Samuele E. Burastero, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 346-346
Open Access | Times Cited: 24
The Conundrum of Lung Disease and Drug Hypersensitivity‐like Reactions in Systemic Juvenile Idiopathic Arthritis
Bryce A. Binstadt, Peter A. Nigrović
Arthritis & Rheumatology (2022) Vol. 74, Iss. 7, pp. 1122-1131
Open Access | Times Cited: 36
Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1β and IL-18
Julia E. Rood, Ayman Rezk, Jennifer Pogoriler, et al.
Journal of Clinical Immunology (2022) Vol. 43, Iss. 1, pp. 101-108
Closed Access | Times Cited: 32
Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
William G Ambler, Kabita Nanda, Karen Onel, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1839-1850
Open Access | Times Cited: 28
Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review
Chun‐Bing Chen, Wei‐Kai Hung, Chuang‐Wei Wang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18
Treatment of systemic juvenile idiopathic arthritis
Claas Hinze, Dirk Foell, Christoph Kessel
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 12, pp. 778-789
Closed Access | Times Cited: 17
Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
Sara Bindoli, Chiara Baggio, Andrea Doria, et al.
Drugs (2024) Vol. 84, Iss. 3, pp. 257-274
Open Access | Times Cited: 7
Atopy as Immune Dysregulation: Offender Genes and Targets
Maryam Vaseghi‐Shanjani, Andrew L. Snow, David J. Margolis, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 7, pp. 1737-1756
Closed Access | Times Cited: 23
Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
Deepak Chellapandian, Diana Milojevic
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 14
Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic‐Exposed Children With Systemic Juvenile Idiopathic Arthritis
Holly Wobma, Sage R. Arvila, Maria L. Taylor, et al.
Arthritis Care & Research (2023) Vol. 75, Iss. 10, pp. 2063-2072
Open Access | Times Cited: 14
Recombinant Interleukin‐1 Receptor Antagonist Is an Effective First‐Line Treatment Strategy in New‐Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA‐DRB1 Background and IL1RN Variants
Remco Erkens, Jorg J. A. Calis, Anouk Verwoerd, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 1, pp. 119-129
Open Access | Times Cited: 13
HLA–DRB1*15 and Eosinophilia Are Common Among Patients With Systemic Juvenile Idiopathic Arthritis
Alison M. Lerman, Shawn A. Mahmud, Zineb Alfath, et al.
Arthritis Care & Research (2023) Vol. 75, Iss. 10, pp. 2082-2087
Open Access | Times Cited: 11
Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis
Holly Wobma, Ronny Bachrach, Joseph B. Farrell, et al.
ACR Open Rheumatology (2023) Vol. 5, Iss. 10, pp. 556-562
Open Access | Times Cited: 11
Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease
Yannan Huang, Laura Sompii‐Montgomery, Jessica Patti, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 3, pp. 328-339
Open Access | Times Cited: 11
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry
Piero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 7, pp. 1141-1152
Closed Access | Times Cited: 4
Annals of the Rheumatic Diseases Collection on juvenile idiopathic arthritis (JIA) 2019-2024
Lianne Kearsley‐Fleet, Samantha Smith, Athimalaipet V Ramanan, et al.
Annals of the Rheumatic Diseases (2025)
Closed Access
Rescue of Pap-Mas in Systemic JIA Using Janus Kinase Inhibitors, Case Report and Systematic Review
Franck Zekre, Anita Duncan, Audrey Laurent, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2702-2702
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top